Cargando…

ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells

BACKGROUND: Unrepaired DNA double-stranded breaks (DSBs) cause chromosomal rearrangements, loss of genetic information, neoplastic transformation or cell death. The nonhomologous end joining (NHEJ) pathway, catalyzing sequence-independent direct rejoining of DSBs, is a crucial mechanism for repairin...

Descripción completa

Detalles Bibliográficos
Autores principales: Maas, Sarah A, Donghia, Nina M, Tompkins, Kathleen, Foreman, Oded, Mills, Kevin D
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984387/
https://www.ncbi.nlm.nih.gov/pubmed/20979627
http://dx.doi.org/10.1186/1741-7007-8-132
_version_ 1782192076281085952
author Maas, Sarah A
Donghia, Nina M
Tompkins, Kathleen
Foreman, Oded
Mills, Kevin D
author_facet Maas, Sarah A
Donghia, Nina M
Tompkins, Kathleen
Foreman, Oded
Mills, Kevin D
author_sort Maas, Sarah A
collection PubMed
description BACKGROUND: Unrepaired DNA double-stranded breaks (DSBs) cause chromosomal rearrangements, loss of genetic information, neoplastic transformation or cell death. The nonhomologous end joining (NHEJ) pathway, catalyzing sequence-independent direct rejoining of DSBs, is a crucial mechanism for repairing both stochastically occurring and developmentally programmed DSBs. In lymphocytes, NHEJ is critical for both development and genome stability. NHEJ defects lead to severe combined immunodeficiency (SCID) and lymphoid cancer predisposition in both mice and humans. While NHEJ has been thoroughly investigated in lymphocytes, the importance of NHEJ in other cell types, especially with regard to tumor suppression, is less well documented. We previously reported evidence that the NHEJ pathway functions to suppress a range of nonlymphoid tumor types, including various classes of sarcomas, by unknown mechanisms. RESULTS: Here we investigate roles for the NHEJ factor ARTEMIS in multipotent mesenchymal stem/progenitor cells (MSCs), as putative sarcomagenic cells of origin. We demonstrate a key role for ARTEMIS in sarcoma suppression in a sensitized mouse tumor model. In this context, we found that ARTEMIS deficiency led to chromosomal damage but, paradoxically, enhanced resistance and proliferative potential in primary MSCs subjected to various stresses. Gene expression analysis revealed abnormally regulated stress response, cell proliferation, and signal transduction pathways in ARTEMIS-defective MSCs. Finally, we identified candidate regulatory genes that may, in part, mediate a stress-resistant, hyperproliferative phenotype in preneoplastic ARTEMIS-deficient MSCs. CONCLUSIONS: Our discoveries suggest that Art prevents genome damage and restrains proliferation in MSCs exposed to various stress stimuli. We propose that deficiency leads to a preneoplastic state in primary MSCs and is associated with aberrant proliferative control and cellular stress resistance. Thus, our data reveal surprising new roles for ARTEMIS and the NHEJ pathway in normal MSC function and fitness relevant to tumor suppression in mesenchymal tissues.
format Text
id pubmed-2984387
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29843872010-11-18 ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells Maas, Sarah A Donghia, Nina M Tompkins, Kathleen Foreman, Oded Mills, Kevin D BMC Biol Research Article BACKGROUND: Unrepaired DNA double-stranded breaks (DSBs) cause chromosomal rearrangements, loss of genetic information, neoplastic transformation or cell death. The nonhomologous end joining (NHEJ) pathway, catalyzing sequence-independent direct rejoining of DSBs, is a crucial mechanism for repairing both stochastically occurring and developmentally programmed DSBs. In lymphocytes, NHEJ is critical for both development and genome stability. NHEJ defects lead to severe combined immunodeficiency (SCID) and lymphoid cancer predisposition in both mice and humans. While NHEJ has been thoroughly investigated in lymphocytes, the importance of NHEJ in other cell types, especially with regard to tumor suppression, is less well documented. We previously reported evidence that the NHEJ pathway functions to suppress a range of nonlymphoid tumor types, including various classes of sarcomas, by unknown mechanisms. RESULTS: Here we investigate roles for the NHEJ factor ARTEMIS in multipotent mesenchymal stem/progenitor cells (MSCs), as putative sarcomagenic cells of origin. We demonstrate a key role for ARTEMIS in sarcoma suppression in a sensitized mouse tumor model. In this context, we found that ARTEMIS deficiency led to chromosomal damage but, paradoxically, enhanced resistance and proliferative potential in primary MSCs subjected to various stresses. Gene expression analysis revealed abnormally regulated stress response, cell proliferation, and signal transduction pathways in ARTEMIS-defective MSCs. Finally, we identified candidate regulatory genes that may, in part, mediate a stress-resistant, hyperproliferative phenotype in preneoplastic ARTEMIS-deficient MSCs. CONCLUSIONS: Our discoveries suggest that Art prevents genome damage and restrains proliferation in MSCs exposed to various stress stimuli. We propose that deficiency leads to a preneoplastic state in primary MSCs and is associated with aberrant proliferative control and cellular stress resistance. Thus, our data reveal surprising new roles for ARTEMIS and the NHEJ pathway in normal MSC function and fitness relevant to tumor suppression in mesenchymal tissues. BioMed Central 2010-10-27 /pmc/articles/PMC2984387/ /pubmed/20979627 http://dx.doi.org/10.1186/1741-7007-8-132 Text en Copyright ©2010 Maas et al; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Maas, Sarah A
Donghia, Nina M
Tompkins, Kathleen
Foreman, Oded
Mills, Kevin D
ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
title ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
title_full ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
title_fullStr ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
title_full_unstemmed ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
title_short ARTEMIS stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
title_sort artemis stabilizes the genome and modulates proliferative responses in multipotent mesenchymal cells
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2984387/
https://www.ncbi.nlm.nih.gov/pubmed/20979627
http://dx.doi.org/10.1186/1741-7007-8-132
work_keys_str_mv AT maassaraha artemisstabilizesthegenomeandmodulatesproliferativeresponsesinmultipotentmesenchymalcells
AT donghianinam artemisstabilizesthegenomeandmodulatesproliferativeresponsesinmultipotentmesenchymalcells
AT tompkinskathleen artemisstabilizesthegenomeandmodulatesproliferativeresponsesinmultipotentmesenchymalcells
AT foremanoded artemisstabilizesthegenomeandmodulatesproliferativeresponsesinmultipotentmesenchymalcells
AT millskevind artemisstabilizesthegenomeandmodulatesproliferativeresponsesinmultipotentmesenchymalcells